HomeOKUR • NASDAQ
add
Onkure Therapeutics Inc
Previous close
$2.52
Day range
$2.35 - $2.53
Year range
$1.70 - $19.60
Market cap
32.42M USD
Avg Volume
221.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.00M | 72.92% |
Net income | -15.92M | -67.00% |
Net profit margin | — | — |
Earnings per share | -1.19 | — |
EBITDA | -16.88M | -73.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 96.66M | 402.19% |
Total assets | 99.88M | 307.23% |
Total liabilities | 9.23M | 54.85% |
Total equity | 90.65M | — |
Shares outstanding | 13.51M | — |
Price to book | 0.37 | — |
Return on assets | -39.57% | — |
Return on capital | -43.25% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.92M | -67.00% |
Cash from operations | -14.00M | -31.76% |
Cash from investing | -18.00K | -100.00% |
Cash from financing | -77.00K | -870.00% |
Net change in cash | -14.10M | -32.67% |
Free cash flow | -8.71M | -20.92% |
About
Founded
2011
Headquarters
Website
Employees
46
